The Invisible Inheritance: Newborns Harboring Antibiotic Resistance Genes Within Hours of Birth

VIENNA — In a discovery that challenges long-held assumptions about the sterility of the womb, new research reveals that infants are entering the world already carrying a complex “library” of antibiotic resistance genes (ARGs). A study presented this week at ESCMID Global 2026 found that newborns in a Greek neonatal intensive care unit (NICU) harbored multiple resistance markers in their first stool samples—often within mere hours of delivery. The findings suggest that the “resistome”—the collection of genes that allow bacteria to withstand antibiotics—is established far earlier than previously understood, shaped by maternal transmission and the immediate hospital environment.

A Snapshot of the Neonatal Resistome

Researchers led by Professor Elias Iosifidis at Aristotle University of Thessaloniki investigated the meconium—the thick, dark first stool passed by a baby—of 105 infants admitted to a NICU between July 2024 and July 2025. Unlike later stools, meconium offers a biological record of the environment the infant experienced in utero and during the first moments of life.

Using advanced molecular screening, the team tested for 56 specific resistance genes. The results were striking:

• Ubiquity: Nearly every infant in the study carried ARGs within hours of birth.

• Common Culprits: The genes oqxA and qnrS, which reduce the effectiveness of broad-spectrum antibiotics, were found in 98% and 96% of samples, respectively.

• High-Stakes Resistance: Roughly 21% of the newborns carried genes resistant to carbapenems, a “last-line” class of antibiotics reserved for the most severe, multidrug-resistant infections.

• Diversity: On average, each infant carried a median of eight different resistance genes before they had even begun a traditional diet or an extended course of postnatal antibiotics.

“At this stage, the collection of resistance genes is mainly shaped by maternal transmission, delivery mode, and very early hospital exposures,” explained Dr. Argyro Ftergioti, a pediatric infectious disease specialist and the study’s lead reporter.

Moving Beyond the “Sterile Womb” Theory

For decades, the prevailing medical consensus was that the fetal gut was sterile until birth. However, this study adds to a growing body of evidence suggesting that the neonatal gut is exposed to microbial genetic material well before a baby takes their first breath.

While the presence of these genes does not mean the infant has an active infection, it does mean the “blueprint” for resistance is present. These genes can move between different types of bacteria through horizontal gene transfer. In a NICU setting, where infants are vulnerable and medical interventions are frequent, this early genetic reservoir could complicate treatment if an infection does arise.

Identifying the Risk Factors: Hospital and Mother

The study went beyond simple detection to identify why certain infants carried more resistance markers than others. The researchers identified a clear link between the “resistome” and the clinical history of both the mother and the child:

1. Maternal Hospitalization: Infants whose mothers were hospitalized during pregnancy were more likely to carry the msrA gene (linked to resistance against macrolide antibiotics). This suggests that “hospital-acquired” resistance patterns can be passed from mother to child.

2. Invasive Procedures: Newborns who received a central venous catheter within their first 24 hours of life showed a higher volume of resistance genes, likely due to the rapid colonization by hospital-adapted microbes.

3. The Resuscitation Paradox: Interestingly, infants requiring resuscitation immediately after birth had fewer resistance genes on average. Researchers cautioned that this might not be a protective effect of resuscitation itself, but rather a reflection of different microbial exposures or the specific clinical circumstances of those high-urgency deliveries.

Expert Perspective: Concern Without Panic

While the data is sobering, independent experts urge a balanced interpretation. The presence of a gene is a “potential” for resistance, not a diagnosis of illness.

“The detection of resistance genes in the gut is different from saying a child is infected with a drug-resistant bug,” says Dr. Uma Bhat, a pediatric infectious disease specialist not involved in the Greek study. “This kind of work is essential for understanding how resistance spreads, but it should not make parents fear that their newborns are ‘doomed’ to untreatable infections.”

Instead, the study serves as a “canary in the coal mine” for public health, highlighting how deeply antibiotic resistance has permeated the human microbiome.

Global Context and Public Health Implications

The Thessaloniki study mirrors findings from international projects like BARNARDS, which investigated neonatal sepsis in low- and middle-income countries. That research similarly found that resistant bacteria identified in mothers often appeared in their newborns almost immediately.

For the medical community, the implications are clear:

• Stewardship is Vital: Antimicrobial stewardship—the effort to use the right drug at the right dose only when necessary—must extend to expectant mothers to prevent the “seeding” of resistant genes.

• Infection Control: The study reinforces the need for meticulous hygiene and infection-control protocols in NICUs and maternity wards to limit the transmission of hospital-adapted strains.

Study Limitations

As with any single-center study, there are caveats. The research involved a relatively small sample of 105 infants in one specific geographic location. The findings may vary in different countries or in community-birth settings versus high-intensity NICUs. Furthermore, the study did not track the infants long-term to see if these early ARGs led to actual health complications later in childhood.

The Path Forward: What This Means for You

For health-conscious parents, this research is a reminder that antibiotic resistance is a global environmental challenge, not just a personal one. While you cannot control every microbe your child encounters, you can contribute to a healthier “resistome” by:

• Judicious Antibiotic Use: Only using antibiotics when strictly necessary and as prescribed by a healthcare provider.

• Prenatal Health: Following recommended vaccination and hygiene guidelines during pregnancy to minimize the need for medical interventions.

• Open Dialogue: Discussing the necessity of any antibiotic treatments with your obstetrician or pediatrician.

As science continues to map the earliest days of human life, it becomes increasingly clear that our microbial journey begins much sooner than we once thought. Protecting that journey requires a global commitment to preserving the power of our most life-saving drugs.

References

• https://www.news-medical.net/news/20260420/Newborns-carry-antibiotic-resistance-genes-within-first-hours-of-life.aspx

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.